AT
REGN icon

Avalon Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Avalon Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$563 – 592
2025
Q3 		$563 Sell
1
-49
-98% -$27.7K ﹤0.01% 538
2025
Q2 		$26.3K Hold
50
– – ﹤0.01% 310
2025
Q1 		$31.7K Hold
50
– – ﹤0.01% 304
2024
Q4 		$35.6K Buy
+50
New +$42K ﹤0.01% 252
2024
Q1 		– Sell
-10
Closed -$8.78K – 348
2023
Q4 		$8.78K Hold
10
– – ﹤0.01% 301
2023
Q3 		$8.23K Hold
10
– – ﹤0.01% 269
2023
Q2 		$7.19K Hold
10
– – ﹤0.01% 285
2023
Q1 		$8.22K Buy
+10
New +$7.54K ﹤0.01% 274

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Avalon Trust's REGN Position: Q4 2025 in Review

Avalon Trust sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 1 share — an estimated $563 sold.

Avalon Trust first reported a position in REGN in Q1 2023 and held it in 8 quarters. The position peaked at $35.6K in Q4 2024. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Avalon Trust reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Avalon Trust sold 1 Regeneron Pharmaceuticals share in Q4 2025, an estimated $563.
  • Avalon Trust first reported a position in Regeneron Pharmaceuticals in Q1 2023 and held it in 8 quarters.
  • Avalon Trust's Regeneron Pharmaceuticals position peaked at $35.6K in Q4 2024.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.